Bret discusses Omnipod's strategy of offering sensor choice, including Dexcom G six and upcoming G seven, as well as the Abbott Libre two. The focus is on providing users with options for their insulin delivery system, emphasizing the importance of interoperability for patient preference and ease of use.
